Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
ALXN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.01%72.511.0%$1888.07m
AMGNAmgen, Inc. -2.43%197.811.3%$881.42m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$848.08m
BIIBBiogen, Inc. -7.31%293.271.5%$703.75m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$557.47m
MRNAModerna, Inc. -0.94%29.670.0%$530.64m
ILMNIllumina, Inc. -6.10%256.463.5%$443.43m
ALXNAlexion Pharmaceuticals, Inc. 0.16%89.932.0%$286.49m
AAgilent Technologies, Inc. -3.67%68.991.6%$220.20m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$187.28m
INCYIncyte Corp. 1.30%74.182.5%$178.88m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$164.58m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$163.42m
NVAXNovavax, Inc. 3.31%14.03114.7%$128.96m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$98.37m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.